Cullinan Oncology, Inc. (CGEM) Tops Q3 EPS by 18c

Cullinan Oncology, Inc. (NASDAQ: CGEM) reported Q3 EPS of ($0.77), $0.18 better than the analyst estimate of ($0.95).

For earnings history and earnings-related data on Cullinan Oncology, Inc. (CGEM) click here.

You May Also Be Interested In

• Dell’s earning report was bullish for Intel CPU demand, analyst says
• Jefferies says retail fund inflows reach $25.3bn in latest week
• Blue Owl Is Said To Plan Public Company For Data Center Roll-up - Bloomberg